Skip to main content

Table 3 LOH profiles in 16 patients with CHC

From: Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study

Case no.

Tumor component

LOH locus

Different LOH

Informative loci

Different LOH/informative loci (%)

Clonality diagnosis

D4S402

D4S406

D17S831

D16S505

D17S938

D8S277

D16S514

D8S520

D8S258

D8S264

1

T1

NI

F

2

8

25.0

SO

 

T2

F

    

2

T1

NI

F

2

7

28.5

SO

 

T2

NI

F

    

3

T1

2

8

25.0

SO

 

T2

F

F

    

4

T1

F

2

7

28.5

SO

 

T2

NI

F

NI

    

5

T1

2

9

22.2

SO

 

T2

F

    

6

T1

NI

F

2

8

25.0

SO

 

T2

    

7

T1

F

NI

2

7

28.5

SO

 

T2

F

    

8

T1

F

2

8

25.0

SO

 

T2

NI

    

9

T1

NI

2

9

22.2

SO

 

T2

    

10

T1

F

2

8

25.0

SO

 

T2

NI

    

11

T1

NI

F

2

8

25.0

SO

 

T2

F

    

12

T1

F

2

9

22.2

SO

 

T2

F

    

13

T1

F

2

9

22.2

SO

 

T2

    

14

T1

2

8

25.0

SO

 

T2

F

NI

    

15

T1

NI

2

8

25.0

SO

 

T2

F

    

16

T1

F

2

8

25.0

SO

 

T2

NI

    
  1. LOH loss of heterozygosity, CHC combined hepatocellular and cholangiocarcinoma, T1 HCC component of CHC, T2 ICC component of CHC, LOH, ▲ missing but not in the same band, retain, NI non-informative, F not done, SO single clonal origin, MO multiple clonal origins